We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

688122:SSEWestern Superconducting Technologies Co Ltd Class A Analysis

Data as of 2026-06-13 - not real-time

CN¥54.41

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Technical outlook: The stock is trading well beneath its short‑term and medium‑term moving averages, confirming a bearish price trajectory. Momentum indicators are in the oversold region, yet the MACD remains negative, and volume has been tapering, suggesting limited upward pressure as the price hovers just above a key support level.
Fundamental backdrop: Revenue growth is essentially flat while margins remain moderate. The balance sheet shows a high debt load relative to equity and free cash flow is negative, raising concerns about cash generation. A discounted cash‑flow model points to a fair value dramatically lower than the current market price, and valuation multiples are substantially above industry averages, indicating significant overvaluation. The dividend yield is modest and the payout ratio is high relative to cash flow, questioning its sustainability.
Risk and valuation perspective: Volatility is elevated and beta is near market levels, amplifying price swings. Sector‑specific cyclicality, potential regulatory shifts in China’s industrial policy, and concentration in a single geography add layers of risk. Combined with the overvalued pricing and dividend sustainability doubts, the overall risk profile leans toward the higher end of the spectrum.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • price below all major moving averages
  • negative MACD and declining volume
  • proximity to technical support with limited upside

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • persistent overvaluation relative to fundamentals
  • high debt burden and negative free cash flow
  • modest dividend offering some income cushion

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • structural overvaluation requiring a substantial price correction
  • ongoing cash flow and leverage concerns
  • exposure to sector and regulatory headwinds in China

Key Metrics & Analysis

Financial Health

Revenue Growth0.60%
Profit Margin13.63%
P/E Ratio49.5
ROE10.87%
ROA3.35%
Debt/Equity38.77
P/B Ratio4.9
Op. Cash FlowCN¥293.0M
Free Cash FlowCN¥-203863888
Industry P/E30.6

Technical Analysis

TrendBearish
RSI31.9
SupportCN¥53.01
ResistanceCN¥73.88
MA 20CN¥63.13
MA 50CN¥67.21
MA 200CN¥71.67
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair ValueCN¥3.23
GradeOvervalued
TypeValue
Dividend Yield1.38%

Risk Assessment

Beta1.03
Volatility67.84%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.